Pfizer to invest €32m in Grange Castle facility

Pfizer to invest €32m in Grange Castle facility

By Maurice Garvey

PFIZER confirmed it will produce Covid-19 vaccines at it’s Grange Castle facility – which will be upgraded via an investment of €32.7m and 75 additional roles to be recruited as part of the expansion.

The news was first reported by The Currency on Tuesday night, before Pfizer confirmed it via an announcement on Wednesday.

County Dev Plan Grange Castle 1

Pfizer which is located in Grange Castle is investing €32 million in it’s Clondalkin facility

The pharma giant said since Pfizer and BioNTech started distributing their Covid-19 vaccine in December 2020, the companies have made several enhancements to the vaccine’s supply chain.

In a statement, the company said: “These enhancements include expanding their existing facilities, adding more suppliers, and bringing on additional Pfizer/BioNTech sites and contract manufacturers around the world to produce the vaccine.

“As such, Pfizer is now bringing on additional European-based facility to be a part of the global Pfizer-BioNTech Covid-19 Vaccine supply chain network and Grange Castle will contribute to the worldwide supply of the vaccine.

“Pfizer’s Grange Castle facility will produce mRNA drug substance.  Given the extensive technical transfer process, on-site development, equipment installation and regulatory approvals needed for the sites, we expect both facilities will be brought onto the network by the end of 2021.

“This is a very significant moment for Ireland and for our Grange Castle site. We are immensely proud to be able to play a part in manufacturing Pfizer’s Covid-19 vaccine,” said Dr Paul Duffy, VP, Pfizer Global Supply.

“Since last year, Pfizer in partnership with BioNTech has worked tirelessly to expedite the development, approval and scale-up of our Covid-19 vaccine.

“The company has continually expanded manufacturing capability and external partnerships to deliver increased doses to the world to help defeat this devastating pandemic.”

Pfizer opened a €1.8 billion biotechnology plant at Grange Castle in 2005, expanding it two years later.

Grange Castle is also equipped to develop new treatments and conduct clinical trials.

By subscribing to The Echo you are supporting your local newspaper Click Here: Echo Online.

TAGS
Share This